Welcome! Thank you for connecting to BMG Pharma's LinkedIn profile. BMG Pharma is an Italian B2B biotech company focused on the development and out-licensing of innovative patented products. From prevention to treatment, BMG transforms scientific innovation into healthcare solutions in dermatology, dermal aesthetics, oral care, osteoarthritis and women's health. Relying on its strong portfolio of intellectual property, BMG has developed numerous patented products and functional ingredients to address specific needs by out-licensing its products to a global network of partners. We offer a current and extensive portfolio of marketed products and a full development pipeline of new products based on our innovative Hyaluromimethic® Technology. Hyaluromimethic® Technology is BMG’s patented state of art technology of modifying Sodium Hyaluronate / Hyaluronic Acid on its hydroxylic groups which has become the basis for a new range of products developed by using biocompatible biomaterials derived from this technology.